Laura A. Williams - 15 Jun 2022 Form 3 Insider Report for ARDELYX, INC. (ARDX)

Role: Chief Medical Officer
Signature: /s/ Elizabeth Grammer, Attorney-in-Fact for Laura A. Williams
Issuer symbol: ARDX
Transactions as of: 15 Jun 2022
Net transactions value: $0
Form type: 3
Filing time: 23 Jun 2022, 18:49:03 UTC
Previous filing: 03 Jun 2022
Next filing: 24 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ARDX	Common Stock						243,717	15 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ARDX	Stock Option (Right to Buy)							15 Jun 2022	Common Stock	105,000	$5.19	Direct	F2
holding	ARDX	Stock Option (Right to Buy)							15 Jun 2022	Common Stock	192,000	$0.9900	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 49,582 Restricted stock units.
F2	Twenty Five Percent (25%) of the shares subject to the option vest on November 2, 2021 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
F3	The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.